Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;27: 6199-206.
Piérard GE, Piérard-Franchimont C, Reginster MA, Quatresooz P. Smouldering malignant melanoma and metastatic dormancy: an update and review. Dermatol Res Pract 2012;2012: 461278.
Chu VH, Tetzlaff MT, Torres-Cabala CA, et al. Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas. Biomed Res Int 2013;2013: 898719.
Lian CG, Mihm MC, Piérard GE, Tommasino M. Skin Cancer. In: World Cancer Report 2014. ed. B.W. Stewart and C.P. Wild. Publ. World Health Organization. 2014;
Piérard GE, Piérard-Franchimont C, Hermanns-Lê T, Delvenne P. Cutaneous malignant melanoma: one single disease? Rev Med Liege 2012;67: 458-60.
Riker AI, Enkemann SA, Fodstad O, et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 2008;1: 13.
Liu W, Peng Y, Tobin DJ. A new 12-gene diagnostic biomarker signature of melanoma revealed by integrated microarray analysis. Peer J 2013;1: e49.
Piérard GE, Piérard-Franchimont C. Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas. Eur J Cancer 1997;33: 1888-92.
Piérard GE. Cell proliferation in cutaneous malignant melanoma: relationship with neoplastic progression. ISRN Dermatol 2012;2012: 828146.
Thompson JF, Soong SJ, Balch CM, et al. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol 2011;29: 2199-205.
van den Hurk K, Niessen HE, Veeck J, et al. Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune. Biochimica et Biophysica Acta 2012;1826: 89-102.
Balch CM, Thompson JF, Gershenwald JE, et al. Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients. Ann Surg Oncol 2014;21: 1075-81.
Hermanns-Lê T, Piérard S. Streamlining cutaneous melanomas in young women of the Belgian Mosan Region. Biomed Res Int 2014;2014: 320767:
Piérard GE, Hermanns-Lê T, Piérard S, et al. In vivo skin fluorescence imaging in young Caucasian adults with early malignant melanoma. Clin Cosmet Invest Dermatol, in press
Wang E, Voiculescu S, Le Poole IC, et al. Clonal persistence and evolution during a decade of recurrent melanoma. J Invest Dermatol 2006;126: 1372-7.
McKenzie JA, Grossman D. Role of the apoptotic and mitotic regulator survivin in melanoma. Anticancer Research 2012;32: 397-404.
Attis MG, Vollmer RT. Mitotic rate in melanoma: a reexamination. Am J Clin Pathol 2007;127: 380-4.
Vollmer RT. A probabilistic analysis of mitotic counts in melanoma. Am J Clin Pathol 2014;141: 213-8.
Piérard GE, Piérard-Franchimont C. The proliferative activity of cells of malignant melanomas. Am J Dermatopathol 1984;6 Suppl: 317-23.
Frahm SO, Schubert C, Parwaresch R, Rudolph P. High proliferative activity may predict early metastasis of thin melanomas. Hum Pathol 2001;32: 1376-81.
Plaza JA, Suster D, Perez-Montiel D. Expression of immunohistochemical markers in primary and metastatic malignant melanoma: a comparative study in 70 patients using a tissue microarray technique. Appl Immunohistochem Mol Morphol 2007;15: 421-5.
Muller-Hermelink N, Braumuller H, Pichler B, et al. TNFR1 signaling and IFNgamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell 2008;13: 507-18.
Eyles J, Puaux AL, Wang X, et al. Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. J Clin Invest 2010;120: 2030-9.
Sleeman JP, Nazarenko I, Thiele W. Do all roads lead to Rome? Routes to metastasis development. Int J Cancer 2011;128: 2511-26.
Klein WM, Wu BP, Zhao S, et al. Increased expression of stem cell markers in malignant melanoma. Mod Pathol 2007;20: 102-7.
Schatton T, Frank MH. Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res 2008;21: 39-55.
Shakhova O. Neural crest stem cells in melanoma development. Curr Opin Oncol 2014;26: 215-21.
Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer. Nature 2013;500: 415-21.
Vogelstein B, Papadopoulos N, Velculescu VE, et al. Cancer genome landscapes. Science 2013;339: 1546-58.
Mimeault M, Batra SK. Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas. World J Clin Oncol 2012;3: 32-42.
Hussein MR, Haemel AK, Wood GS. Apoptosis and melanoma: molecular mechanisms. J Pathol 2003;199: 275-88.
Vucic D, Stennicke HR, Pisabarro MT, et al. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 2000;10: 1359-66.
Kasof GM, Gomes BC. Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 2001;276: 3238-46.
Ma S, Rubin BP. Apoptosis-associated tyrosine kinase 1 inhibits growth and migration and promotes apoptosis in melanoma. Lab Invest 2014;94: 430-8.
Piérard-Franchimont C, Henry F, Heymans O, Piérard GE. Vascular retardation in dormant growth-stunted malignant melanomas. Int J Mol Med 1999;4: 403-6.
Eelen G, Cruys B, Welti J, et al. Control of vessel sprouting by genetic and metabolic determinants. Trends Endocrinol Metab 2013;24: 589-96.
Quatresooz P, Piérard GE, Piérard-Franchimont C, et al. Spectral analysis of the microvasculature of primary cutaneous melanoma. Pathol Biol (Paris) 2012;60: 149-53.
Mikesh LM, Kumar M, Erdag G, et al. Evaluation of molecular markers of mesenchymal phenotype in melanoma. Melanoma Res 2010;20: 485-95.
Elder DE. Pathological staging of melanoma. Methods Mol Biol 2014;1102: 325-51.
Claessens N, Piérard GE, Piérard-Franchimont C, et al. Immunohistochemical detection of incipient melanoma micrometastases. Relationship with sentinel lymph node involvement. Melanoma Res 2005;15: 107-10.
Ulmer A, Fischer JR, Schanz S, et al. Detection of melanoma cells displaying multiple genomic changes in histopathologically negative sentinel lymph nodes. Clin Cancer Res 2005;11: 5425-32.
Juratli MA, Sarimollaoglu M, Nedosekin DA, et al. Dynamic fluctuation of circulating tumor cells during cancer progression. Cancers (Basel) 2014;6: 128-42.
Rodic S, Mihalcioiu C, Saleh RR. Detection methods of circulating tumor cells in cutaneous melanoma: A systematic review. Critical Reviews in Oncology/Hematology, Epub Feb 18 2014;
Strauss DC, Thomas JM. Transmission of donor melanoma by organ transplantation. Lancet Oncol 2010;11: 790-6.
Yang ZJ, Chee CE, Huang S, Sinicrope F. Autophagy modulation for cancer therapy. Cancer Biol Ther 2011;11: 169-76.
Mumford BS, Robertson GP. Circulating melanoma cells in the diagnosis and monitoring of melanoma: an appraisal of clinical potential. Mol Diagn Ther 2014;18: 175-83.
Xu X, Gimotty PA, Guerry D, et al. Lymphatic invasion as a prognostic biomarker in primary cutaneous melanoma. Methods Mol Biol 2014;1102: 275-86.
Saluja A, Money N, Zivony DI, Solomon AR. Angiotropic malignant melanoma: a rare pattern of local metastases. J Am Acad Dermatol 2001;44: 829-32.
Lugassy C, Barnhill RL. Angiotropic melanoma and extravascular migratory metastasis: a review. Adv Anat Pathol 2007;14: 195-201.
Shaikh L, Sagebiel RW, Ferreira CM, et al. The role of microsatellites as a prognostic factor in primary malignant melanoma. Arch Dermatol 2005;141: 739-42.
Bodenham DC. A study of 650 observed malignant melanomas in the South-West region. Ann R Coll Surg Engl 1968;43: 218-39.
Rocken M. Early tumor dissemination, but late metastasis: insights into tumor dormancy. J Clin Invest 2010;120: 1800-3.
Klein CA. Framework models of tumor dormancy from patient-derived observations. Curr Opin Genet Dev 2011;21: 42-9.
Goss PE, Chambers AF. Does tumour dormancy offer a therapeutic target? Nat Rev Cancer 2010;10: 871-7.
Gaudi S, Messina JL. Molecular bases of cutaneous and uveal melanomas. Patholog Res Int 2011;2011: 159421.
MacKie RM, Reid R, Junor B. Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med 2003;348: 567-8.
Soikkeli J, Lukk M, Nummela P, et al. Systematic search for the best gene expression markers for melanoma micrometastasis detection. J Pathol 2007;213: 180-9.
